20 articles
Duke University study tests whether targeted brain stimulation can reverse age-related cognitive decline and improve working memory.
A Phase 2 open-label trial explores whether an approved immune drug can raise frataxin protein levels and slow neurological decline in Friedreich Ataxia.
A Phase 1 trial of AV-1959R, an Aฮฒ-targeting vaccine, tests safety and antibody generation in healthy adults aged 40โ60.
Completed study of 102 older adults tested whether combined interventions can preserve brain volume and improve mobility through muscle-brain axis.
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Small study reveals BDNF genetic variant could influence exercise's cognitive and cardiovascular benefits in healthy men.
Clinical trial explores whether resetting gut microbiome through fecal transplants can slow Parkinson's progression and reduce symptoms.
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
King's College study tests whether simple chewing and fasting patterns can enhance cognitive function and neurogenesis in older adults.
12-week intensive cognitive training program tested in 76 adults with early memory problems to assess brain function improvements.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
12-week study reveals how aerobic and strength training improve cognitive performance by altering stress hormones and brain proteins.
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
A 210-person trial tests whether 5-month music therapy programs โ and robotic assistants โ can slow cognitive decline in older adults.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
